*Some Market data delayed by 15 mins.

Smith & Nephew plc

Symbol: SNN (NYSE)
37.17 ▲ (1.74%) 0.635

Company Description:
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Key Stats
  • Today's Open: $36.59
  • Today's High: $37.507
  • Today's Low: $36.421
  • Today's Volume: 479.71K
  • Yesterday Close: $36.53
  • Yesterday High: $36.63
  • Yesterday Low: $36.4
  • Yesterday Volume: 312.87K
  • Last Min Volume: 25
  • Last Min High: $37.165
  • Last Min Low: $37.165
  • Last Min VWAP: $37.165
Company Profile
  • Name: Smith & Nephew plc
  • Website: https://www.smith-nephew.com
  • Listed Date: 1999-11-16
  • Location: ,
  • Market Status: Active
  • CIK Number: 0000845982
  • SIC Code:
  • SIC description:
  • Market Cap: $15.48B
  • Round Lot: 100
  • Outstanding Shares: 423.84M
  • Asset Type: ADRC
RECENT FILINGS FOR SNN
Filing Date Filing Type Format
2025-10-22 6-K View
2025-10-16 6-K View
2025-10-16 6-K View
2025-10-14 6-K View
2025-10-08 6-K View
2025-10-01 6-K View
2025-09-30 6-K View
2025-09-09 6-K View
2025-09-09 6-K View
2025-09-02 6-K View
2025-08-29 6-K View
2025-08-28 6-K View
2025-08-26 6-K View
2025-08-22 6-K View
2025-08-20 6-K View
2025-08-13 6-K View
2025-08-07 6-K View
2025-08-07 6-K View
2025-08-07 6-K View
2025-08-05 6-K View
Latest News on SNN

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.